Family Medicine Doctors in Wayland, MA Accepting Medicare

2 Family Medicine doctors found. Showing 1 - 2

Dr. Tania M Bandak, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Andrew Ave, Wayland, MA 01778 Phone: 781-453-8450    Fax: 781-453-8470

Hila Hoch, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Andrew Ave Ste 101, Wayland, MA 01778 Phone: 781-453-8450    Fax: 781-453-8470

News Archive

Energy drinks with alcohol may increase risk of drinking

Energy drinks mixed with alcohol, such as Red Bull- and vodka, have become trendy. While this consumption has been implicated in risky drinking practices and associated accidents and injuries, there is little laboratory research on how the effects of this combination differ from those of drinking alcohol alone.

Report recommends increasing investment in small-scale farms run by women to achieve hunger MDG

An ActionAid report released on Wednesday recommends that major aid donors increase their support of small-scale farms run by women in developing countries to maximize the chance of meeting the U.N. Millennium Development Goal of halving hunger by 2015, Reuters reports.

Liquidia commences dosing in LIQ-001 Phase 1 trial for seasonal influenza

Liquidia Technologies, a privately held nanotechnology company developing particle-based vaccines and therapeutics, today announced the initiation of human dosing of its lead vaccine product candidate, LIQ-001, in a Phase 1 clinical trial. LIQ-001, the first in a pipeline of PRINT® vaccines, is being developed as a seasonal influenza vaccine for enhanced protection in the elderly and represents the company's migration from proof of concept to the clinical application of PRINT technology.

PhaseBio raises $48.4M in Series B financing

PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has raised a total of $48.4 million from its Series B financing following receipt of the third tranche to advance the company's product development programs.

FDA declines to grant Levulan PDT Orphan Designation: DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. reported today that on the afternoon of August 5, 2010 the U.S. Food and Drug Administration notified DUSA that it has not granted Orphan Drug Designation for the use of Levulan (aminolevulinic acid HCl) Photodynamic Therapy for the prevention of cutaneous squamous cell carcinomas in patients who have a proven history of multiple localized cutaneous SCCs over a 12 month period.

Read more Medical News

› Verified 5 days ago